Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

US-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with ...

More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.

It undergoes rigorous evaluation through Phase 1, Phase 2, and Phase 3 trials to assess its safety ... Novo Nordisk manufactures the popular weight-loss drug Wegovy, and its type 2 diabetes drug ...

Shrotriya, the Managing Director of Novo Nordisk, which manufactures the wildly popular Ozempic and Wegovy, stressed on the ABC (attitude, behaviour and choices) mantra, which is integral to the ...

Each Ozempic pen holds several doses of the drug ... your doctor may increase your dose by up to 1 mg. Your dosage adjustment will depend on your current dosage and how well it’s working ...

Ozempic, Wegovy and similar drugs are, without a doubt, revolutionising medicine. They have transformed our ability to manage obesity and type 2 diabetes, but have actually shown potential for a ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug more accessible for some patients.